Advances in the extracellular domain of p75 neurotrophin receptor in the prevention and therapy of Alzheimer's disease
10.3760/cma.j.issn.1006-7876.2019.03.011
- VernacularTitle:p75神经营养因子受体胞外域在阿尔茨海默病防治中的研究进展
- Author:
Huayi LIU
1
;
Taotao ZHANG
;
Juanhua GU
;
Yueqin ZENG
Author Information
1. 昆明医科大学分子临床医学研究院暨云南省干细胞及再生医学重点实验室 650500
- Keywords:
Extracellular domain of p75 neurotrophin receptor;
Alzheimer disease;
Progress
- From:
Chinese Journal of Neurology
2019;52(3):226-231
- CountryChina
- Language:Chinese
-
Abstract:
Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive impairments with progressive loss of memory and behavioral disorder.Up to now,there is no effective therapy or drug to cure AD.Recent studies have shown p75 neurotrophin receptor (p75NTR) plays a critical role in the pathogenesis of AD,while the extracellular domain of p75 neurotrophin receptor (p75ECD) has neuroprotective effect and can attenuate the development and progression of AD.Therefore,p75ECD is a research-hotspot for prevention and treatment of AD.Here,recent studies are reviewed to learn about the advances of p75ECD in the prevention and therapy of AD and provide references for getting novel methods and drugs to treat AD.